Functional precision medicine: the future of cancer care
Functional precision medicine (FPM), combining ex vivo drug sensitivity testing with genomic profiling to identify treatment options for recurrent/refractory cancer, is feasible and poised to accelerate. This forum explores the history of FPM, recent clinical advancements, and barriers to expanding the clinical utility and accessibility for pediatric/adolescent and adult cancers.
Authors
- Arlet Acanda de la Rocha (ORCID: https://orcid.org/0000-0002-0426-632X)
- Diana J. Azzam (ORCID: https://orcid.org/0000-0002-2605-8855)
- Noah Berlow (ORCID: https://orcid.org/0000-0001-8666-3152)
Institutions
- Florida International University (US)
- Health First (US)
Publication Details
- Journal
- Trends in Molecular Medicine
- Published
- 2024-11-19
- DOI
- https://doi.org/10.1016/j.molmed.2024.10.015
- Citations
- 6
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 1.71